Abstract
Four new angucyclin(on)es, 11-deoxylandomycinone (1) and landomycins X-Z (2-4) were isolated from the crude extract of Streptomyces cyanogenus K62 mutant strain, along with the recently reported landomycins S, T and V (5-7) and five other known compounds. The structures of the new compounds 1-4 were elucidated by 1D and 2D NMR studies along with HR-MS analyses. Unique about the structures is that the fourth sugar moiety (sugar D) in landomycins X-Z (2-4) was β-D-amicetose instead of β-D-olivose, usually found in this position. The new angucyclin(on)es were biologically evaluated in comparison with previously known congeners against a small panel of MCF-7 (estrogen responsive) and MDA 231 (estrogen refractory) breast cancer cell lines. 11- deoxylandomycinone (IC50 2.1±0.3 and 1.2±0.4 μM) and landomycin Y (IC50 1.0±0.1 and 2.0±0.1 μM) showed the highest cytotoxic potencies against both the cell lines.
| Original language | English |
|---|---|
| Pages (from-to) | 141-150 |
| Number of pages | 10 |
| Journal | Journal of Antibiotics |
| Volume | 64 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2011 |
Bibliographical note
Funding Information:The mass spectrometry department, University of Wisconsin Biotechnology Centre is acknowledged for the HR-MS data. This work was supported by grant CA 102102 from the US National Institutes of Health to JR.
Funding
The mass spectrometry department, University of Wisconsin Biotechnology Centre is acknowledged for the HR-MS data. This work was supported by grant CA 102102 from the US National Institutes of Health to JR.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Childhood Cancer Registry – National Cancer Institute | R01CA102102 |
Keywords
- angucyclines
- anticancer agents
- cytotoxicity
- landomycins
- polyketides
- structureactivity relationships
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery